US Stocks
/
Alumis Inc. Share Price

Alumis Inc. Share Price

NASDAQ: ALMS | Mid Cap
$27.52
-$0.11 (-0.4%) Last updated on 11 Aug, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Alumis Inc. Stock Performance

Open
$27.46
Prev. Close
$27.64
Circuit Range
N/A
Day Range
$27.13 - $27.93
Year Range
$3.76 - $31.30
Volume
20,203
Average Traded
$27.43

Alumis Inc. Share Price Today

As of 11 August 2026, Alumis Inc.'s share price is $27.52. The stock opened at $27.46, compared to its previous close of $27.64. During today's trading session, Alumis Inc.'s share price traded between $27.13 and $27.93, with an average price of $27.53. Over the past 52 weeks, the stock has recorded a high of $31.30 and a low of $3.76. In terms of performance, Alumis Inc.'s share price has declined by 7.17% over the last six months and is up 491.30% on a year-on-year basis.

Alumis Inc. Share Price Chart

$27.13$27.93
L
Show Current Price
H

Alumis Inc. Stock Fundamentals & Key Indicators

Market Cap
$2.34B
PE Ratio (TTM)
-9.62
Dividend Yield
N/A
EPS (TTM)
$-2.86
Revenue (TTM)
$24.05M
Return On Equity (TTM)
-80.76%
Profit Margin
-1011.75%
Debt to Equity
0.24
Quarterly Earnings Growth YoY
-18.94%

Alumis Inc. Quarterly Profit & Loss

All figures in USD

ParticularsJun 2024Sep 2024Mar 2025Jun 2025Sep 2025
RevenueN/AN/AN/AN/AN/A
Net Profit-$56.51M-$93.12M-$98.96M$59.32M-$110.75M
Net Profit MarginN/AN/AN/AN/AN/A
Income ChangeN/A-64.79%-6.28%159.94%-286.70%

Alumis Inc. Annual Profit & Loss

All figures in USD

Particulars2025
Revenue$24.05M
Net Profit-$243.32M
Net Profit Margin-1011.75%
Income ChangeN/A

About Alumis Inc.

Alumis Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of medicines for autoimmune disorders. The company's clinical asset comprises ESK-001, an allosteric tyrosine kinase 2 (TYK2) inhibitor for the treatment of plaque psoriasis and systemic lupus erythematosus; and A-005, a central nervous system-penetrant allosteric TYK2 inhibitor for neuroinflammatory and neurodegenerative diseases. It also develops interferon regulatory factor 5 (IRF5) to address immune dysfunction. The company was formerly known as Esker Therapeutics, Inc. and changed its name to Alumis Inc. in January 2022. The company was incorporated in 2021 and is headquartered in South San Francisco, California.

Alumis Inc. Historical Returns

MonthOpenCloseChange %
Aug 2026
$27.25
$27.50
-2.50%
Jul 2026
$27.65
$28.21
+0.36%
Jun 2026
$20.94
$28.11
+30.17%
May 2026
$25.06
$21.59
-12.43%
Apr 2026
$23.14
$24.66
+11.94%
Mar 2026
$29.00
$22.03
-25.70%
Feb 2026
$24.48
$29.65
+20.97%
Jan 2026
$9.49
$24.51
+151.38%
Dec 2025
$7.67
$9.75
+27.04%
Nov 2025
$4.70
$7.67
+62.26%
Oct 2025
$4.00
$4.73
+18.84%
Sep 2025
$4.62
$3.98
-14.50%

ALMS Share Price FAQs

What is Alumis Inc. share price today?

chevron-up
Alumis Inc. share price today is $27.52 as on August 11, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Alumis Inc. stock?

chevron-up
The 52 week high of Alumis Inc. stock is $31.30, while the 52 week low is $3.76 as of 11 Aug '26.

What is ALMS's market capitalisation today?

chevron-up
ALMS market capitalisation is $2.34B as of August 11, 2026, at 9:11 am IST.

What is ALMS's net income for the last quarter?

chevron-up
ALMS's net income for the last quarter is -0.11B USD.

What is the 5 year returns of ALMS?

chevron-up
The 5 year returns of ALMS is 113.37% as on 11 Aug '26.

What is the high & low stock price of ALMS today?

chevron-up
ALMS stock price hit a high of $27.93 and low of $27.13 as of 11 Aug '26.

Can I buy ALMS shares in India?

chevron-up
Yes. You can buy ALMS in India by opening an international trading account.